1. Adjuvant Radiation Therapy for Ductal Carcinoma In Situ of the Breast: A Clinician’s Dilemma

   • Chirag Shah
   • Frank Vicini

   ASO Perspectives 06 June 2023 Pages: 6281 - 6283

2. Quality of ChatGPT Responses to Questions Related to Pancreatic Cancer and its Surgical Care

   • Zorays Moazzam
   • Jordan Cloyd
   • Timothy M. Pawlik

   ASO Research Letter 22 June 2023 Pages: 6284 - 6286

3. Creation and Implementation of a Monthly International Tumor Board: Experience of the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)

   • Jason K. Sicklick
   • Carol J. Swallow
   • Alessandro Gronchi

   ASO Research Letter 24 July 2023 Pages: 6287 - 6289

   

4. Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate

   • Giacomo Montagna
   • Mahmoud B. El-Tamer

   Breast Oncology 02 July 2023 Pages: 6290 - 6292

5. The Era of Flat Closure Mastectomy (Is Still Here). Are You Ready?

   • Jennifer L. Baker

   Breast Oncology 16 August 2023 Pages: 6293 - 6295

6. Phyllodes Tumors of the Breast: Addressing the Gaps in Consensus Recommendations for Clinical Management

   • Anna D. Louie
   • Laura H. Rosenberger

   Breast Oncology 14 August 2023 Pages: 6296 - 6298

7. Validation of the Absent-Cell Theory for Staging Mucinous Appendiceal Cancer

   • Frederick L. Greene

   Peritoneal Surface Malignancy 15 July 2023 Pages: 6299 - 6300

8. Perioperative Systemic Chemotherapy in Patients with Malignant Peritoneal Mesothelioma Undergoing Cytoreduction and HIPEC: Don’t Put the Cart Before the Horse

   • H. Richard Alexander

   Peritoneal Surface Malignancy 26 June 2023 Pages: 6301 - 6303

9. Neoadjuvant Chemotherapy for Intrahepatic Cholangiocarcinoma: A Potential Paradigm Shift in Treatment Sequencing

   • Aslam Ejaz
   • Timothy M. Pawlik

   Hepatobiliary Tumors 26 July 2023 Pages: 6304 - 6305

10. Editorial Comment on: The Impact of Programmed Death-Ligand 1 Expression on Mismatch Repair Deficiency and Epstein–Barr Virus Status on Survival Outcomes in Patients with Stage II/III Gastric Cancer After Surgery

    • Takehiko Yokobori

    Gastrointestinal Oncology 14 June 2023 Pages: 6306 - 6307

11. Peritoneal Cell-Free DNA: A Novel Biomarker for Recurrence in Pancreatic Cancer

    • Angela Sickels
    • Tejeshwar Jain
    • Vikas Dudeja

    Pancreatic Tumors 23 July 2023 Pages: 6308 - 6310

12. Commentary: Validation of Sublobar Resection for Middle Third Tumors: Advanced Imaging Technology Affords Patients a Viable Alternative to Lobectomy

    • Eric A. Lisznyai
    • Andrew M. Popoff

    Thoracic Oncology 22 July 2023 Pages: 6311 - 6312

13. Surgical Management of Incidentally Detected Pleural Disease in Lung Cancer Patients: A Complex Decision

    • Sukumar Kalvapudi
    • Sai Yendamuri

    Thoracic Oncology 07 July 2023 Pages: 6313 - 6314

14. Difficulty of Video-Assisted Thoracoscopic Surgery Segmentectomy: Proposal for a New Classification System—All “Segmentectomies” Are Not Created Equal

    • Scott J. Swanson

    Thoracic Oncology 15 July 2023 Pages: 6315 - 6315

15. Editorial: Different Methods of Minimally Invasive Esophagojejunostomy After Total Gastrectomy for Gastric Cancer: Outcomes from Two Experienced Centers

    • Benjamin R. Veenstra
    • Matthew E. Dixon
    • Sam G. Pappas

    Thoracic Oncology 12 August 2023 Pages: 6316 - 6317

16. Great Debates in Surgical Oncology: An Annals of Surgical Oncology Series

    • Mitchell C. Posner
    • Kelly M. McMasters

    Global Health Services Research 18 July 2023 Pages: 6318 - 6318

17. Great Debate: Limb Infusion for Melanoma: A Thing of the Past?

    • Kristen E. Rhodin
    • Douglas S. Tyler
    • Georgia M. Beasley

    Melanoma 17 July 2023 Pages: 6319 - 6324

    

18. Top Melanoma Articles from 2021 to Inform Your Cancer Practice

    • Jeffrey E. Gershenwald

    Melanoma 26 July 2023 Pages: 6325 - 6331

19. The Association Between Pregnancy Timing and Cumulative Exposure on Survival in Melanoma

    • Sarah B. Bateni
    • Rinku Sutradhar
    • Nicole J. Look Hong

    Melanoma 29 June 2023 Pages: 6332 - 6338

20. ASO Visual Abstract: The Association Between Pregnancy Timing and Cumulative Exposure on Survival in Melanoma

    • Sarah B. Bateni
    • Rinku Sutradhar
    • Nicole J. Look Hong

    ASO Visual Abstract 05 August 2023 Pages: 6339 - 6339

21. Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?

    • Kristen E. Rhodin
    • Sin-Ho Jung
    • Georgia M. Beasley

    Melanoma 22 July 2023 Pages: 6340 - 6352

    

22. ASO Author Reflections: It’s About Time?

    • Kristen E. Rhodin
    • Georgia M. Beasley

    ASO Author Reflections 23 July 2023 Pages: 6353 - 6354

23. ASO Visual Abstract: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does It Matter?

    • Kristen E. Rhodin
    • Sin-Ho Jung
    • Georgia M. Beasley

    ASO Visual Abstract 14 August 2023 Pages: 6355 - 6356

24. RE: A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma

    • Peter A. Prieto
    • Matthew S. Goldberg
    • Brian Martin

    Melanoma Open access 03 July 2023 Pages: 6357 - 6358

25. The Role of Clinicopathologic Nomograms for Melanoma in the Era of Gene Expression Profiling

    • Raghav Tripathi
    • Karen Larson
    • Wesley Y. Yu

    Melanoma 27 June 2023 Pages: 6359 - 6360

26. Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study

    • Frederikke Munck
    • Pernille Jepsen
    • Tove H. F. Tvedskov

    Breast Oncology Open access 03 July 2023 Pages: 6361 - 6369

    

27. ASO Author Reflections: Comparison of Two-Step Methods for Targeted Axillary Dissection in Denmark

    • Frederikke Munck
    • Niels Kroman
    • Tove Tvedskov

    ASO Author Reflections 23 June 2023 Pages: 6370 - 6371

28. ASO Visual Abstract: Comparing Methods for Targeted Axillary Dissection in Breast Cancer Patients: A Nationwide, Retrospective Study

    • Frederikke Munck
    • Pernille Jepsen
    • Tove H. F. Tvedskov

    ASO Visual Abstract 19 July 2023 Pages: 6372 - 6373

29. National Trends in “Going Flat” After Mastectomy

    • Morgan K. Johnson
    • Chandler S. Cortina
    • Amanda L. Kong

    Breast Oncology 17 July 2023 Pages: 6374 - 6382

    

30. ASO Author Reflections: The Potential Impact of the “Going Flat” Movement on National Rates of Post-Mastectomy Breast Reconstruction

    • Morgan K. Johnson
    • Chandler S. Cortina
    • Amanda L. Kong

    ASO Author Reflections 13 July 2023 Pages: 6383 - 6384

31. ASO Visual Abstract: National Trends in “Going Flat” After Mastectomy

    • Morgan K. Johnson
    • Chandler S. Cortina
    • Amanda L. Kong

    ASO Visual Abstract 19 July 2023 Pages: 6385 - 6385

32. Phyllodes Tumors of the Breast: Canadian National Consensus Document Using Modified Delphi Methodology

    • Jessica Bogach
    • Apishanthi Sriskandarajah
    • Canadian Phyllodes Tumor Consensus Panel

    Breast Oncology 09 August 2023 Pages: 6386 - 6397

    

33. ASO Author Reflections: Development of Canadian National Consensus Statements on Phyllodes Tumors of the Breast

    • Jessica Bogach
    • Apishanthi Sriskandarajah
    • Nicole Look Hong

    ASO Author Reflections 15 July 2023 Pages: 6398 - 6399

34. ASO Visual Abstract: Phyllodes Tumors of the Breast: Canadian National Consensus Document Using Modified Delphi Methodology

    • Jessica Bogach
    • Apishanthi Sriskandarajah
    • the Canadian Phyllodes Tumor Consensus Panel

    ASO Visual Abstract 09 August 2023 Pages: 6400 - 6400

35. Changes in Surgical Management of the Axilla Over 11 Years – Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial

    • Judy C. Boughey
    • Hongmei Yu
    • Rita A. Mukhtar

    Breast Oncology 28 June 2023 Pages: 6401 - 6410

    

36. ASO Visual Abstract: Changes in Surgical Management of the Axilla Over 11 Years—Report on Over 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial

    • Judy C. Boughey
    • Hongmei Yu
    • Rita Mukhtar

    ASO Visual Abstract 03 August 2023 Pages: 6411 - 6412

37. Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients

    • Elizaveta Vasilyeva
    • Jeremy Hamm
    • Elaine McKevitt

    Breast Oncology 26 June 2023 Pages: 6413 - 6424

    

38. ASO Visual Abstract: Breast-Conserving Therapy is Associated with Improved Survival without an Increased Risk of Locoregional Recurrence Compared to Mastectomy in Both Clinically Node Positive and Node Negative Breast Cancer Patients

    • Elizaveta Vasilyeva
    • Jeremy Hamm
    • Elaine McKevitt

    ASO Visual Abstract 30 July 2023 Pages: 6425 - 6426

39. Landmark Series: The Cancer Genome Atlas and the Study of Breast Cancer Disparities

    • Josh A. Johnson
    • Brandon J. Moore
    • Lisa A. Newman

    Breast Oncology 16 August 2023 Pages: 6427 - 6440

    

40. Neoadjuvant Immunotherapy in Early, Triple-Negative Breast Cancers: Catching Up with the Rest

    • Leah Kim
    • Magdalena Coman
    • Tristen S. Park

    Breast Oncology 22 June 2023 Pages: 6441 - 6449

    

41. ASO Author Reflections: Immunotherapy and Breast Cancer—Spotlight on Early Stage TNBC

    • Tristen S. Park
    • Lajos Pusztai

    ASO Author Reflections 20 July 2023 Pages: 6450 - 6451

42. ASO Visual Abstract: Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancers—Catching up with the Rest

    • Leah Kim
    • Magdalena Coman
    • Tristen S. Park

    ASO Visual Abstract 03 July 2023 Pages: 6452 - 6453

43. Germline Genetic Testing Among Women ≤ 45 Years of Age with Ductal Carcinoma In Situ Versus Invasive Breast Cancer in a Large Integrated Health Care System

    • Diana S. Hsu
    • Sheng-Fang Jiang
    • Veronica C. Shim

    Breast Oncology 29 June 2023 Pages: 6454 - 6461

    

44. Associations Between Hospital Volume and Overall Survival After Surgery in Older Patients with Breast Cancer

    • Sam Z. Thalji
    • Chandler S. Cortina
    • Amanda L. Kong

    Breast Oncology 14 June 2023 Pages: 6462 - 6470

    

45. ASO Author Reflections: Extending Optimal Care for Breast Cancer to the Elderly Population

    • Sam Z. Thalji
    • Chandler S. Cortina
    • Amanda L. Kong

    ASO Author Reflections 27 June 2023 Pages: 6471 - 6472

46. ASO Visual Abstract: Associations Between Hospital Volume on Overall Survival After Surgery in Older Patients with Breast Cancer

    • Sam Z. Thalji
    • Chandler S. Cortina
    • Amanda L. Kong

    ASO Visual Abstract 17 July 2023 Pages: 6473 - 6474

47. Clinical Behavior, Management, and Treatment Response of Estrogen Receptor Low (1–10%) Breast Cancer

    • Dan Moldoveanu
    • Tanya L. Hoskin
    • Judy C. Boughey

    Breast Oncology 17 July 2023 Pages: 6475 - 6483

    

48. ASO Author Reflections: Low Estrogen Receptor (ER) Expression Breast Cancer Behaves More like ER Negative Disease and Influences Management

    • Dan Moldoveanu
    • Matthew P. Goetz
    • Judy C. Boughey

    ASO Author Reflections 24 July 2023 Pages: 6484 - 6485

49. ASO Visual Abstract: Clinical Behavior, Management, and Treatment Response of Estrogen Receptor-Low (1-10%) Breast Cancer

    • Dan Moldoveanu
    • Tanya L. Hoskin
    • Judy C. Boughey

    ASO Visual Abstract 30 July 2023 Pages: 6486 - 6487

50. Intraoperative Examination of Retro-Areolar Margin is not Routinely Necessary During Nipple-Sparing Mastectomy for Cancer

    • Francesca Serio
    • Elena Manna
    • Lucio Fortunato

    Breast Oncology 30 June 2023 Pages: 6488 - 6496